Staar Ramping Up Staarvisc Production Following FDA Approval
This article was originally published in The Gray Sheet
Executive Summary
Staar Surgical's U.S. launch of Staarvisc viscoelastic solution will follow production ramp-up occurring over the next few months, the firm said following receipt of FDA approval July 7.